Alpha 2.0
Login Register
» Authors » Christian Hampp

Christian Hampp

Explore the profile of Christian Hampp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 568
Followers 0
Related Specialties
Pharmacology
Public Health
Pediatrics
Top 10 Co-Authors
Almut G Winterstein
Sengwee Toh
Lockwood Taylor
Kate Gelperin
Teresa L Kauf
Susan E Andrade
Catherine A Panozzo
Leyla Sahin
Steven T Bird
Aarthi Iyer
Published In
Pharmacoepidemiol Drug Saf
Diabetes Care
Drug Saf
Value Health
Pharmacotherapy
Affiliations
Soon will be listed here.
Recent Articles
1.
Balancing the Scales: Optimizing Reporting of Infection Rates in Clinical Trials of Bispecific Antibodies in Multiple Myeloma
Richter J, Dhodapkar M, Li M, Awad M, Hampp C, Knorr K, et al.
Am J Hematol . 2025 Jan; 100(4):548-551. PMID: 39887567
No abstract available.
2.
Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System
Sarayani A, Brown J, Hampp C, Donahoo W, Winterstein A
Clin Epidemiol . 2023 Jun; 15:645-660. PMID: 37274833
Background: High-Dimensional Propensity Score procedure (HDPS) is a data-driven approach to assist control for confounding in pharmacoepidemiologic research. The transition to the International Classification of Disease (ICD-9/10) in the US...
3.
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy
Sarayani A, Donahoo W, Hampp C, Brown J, Winterstein A
Ann Intern Med . 2023 Mar; 176(4):443-454. PMID: 36940443
Background: The U.S. Food and Drug Administration approved phentermine-topiramate for obesity in 2012 and required a Risk Evaluation and Mitigation Strategy (REMS) to prevent prenatal exposure. No such requirement was...
4.
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing
Sarayani A, Hampp C, Brown J, Donahoo W, Winterstein A
Drug Saf . 2022 Nov; 45(12):1517-1527. PMID: 36318419
Introduction: The US FDA required a Risk Evaluation and Mitigation Strategy (REMS) for phentermine/topiramate, an anti-obesity medication, to prevent congenital malformations. No REMS is required for single-ingredient topiramate, which may...
5.
Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines
Choi Y, Meissner H, Hampp C, Park H, Winterstein A
Eur J Pediatr . 2021 Aug; 181(2):841-845. PMID: 34365543
Guidelines from the American Academy of Pediatrics recommend palivizumab immunoprophylaxis for children with CLD in their second year of life if they continue to need treatment within 6 months before...
6.
Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization
Choi Y, Meissner H, Hampp C, Park H, Brumback B, Winterstein A
J Pediatric Infect Dis Soc . 2020 Sep; 10(3):317-325. PMID: 32978942
Background: Guidelines assume children with chronic lung disease (CLD) who require medical support within 6 months before the second respiratory syncytial virus (RSV) season remains at high risk of severe...
7.
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy
Zhu Y, Hampp C, Wang X, Albogami Y, Wei Y, Brumback B, et al.
Pharmacoepidemiol Drug Saf . 2020 Sep; 29(11):1414-1422. PMID: 32909348
Purpose: Accurate ascertainment of gestational age (GA) has been a challenge in perinatal epidemiologic research. To date, no study has validated GA algorithms in Medicaid Analytic eXtract (MAX). Methods: We...
8.
Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial
Sharretts J, Galescu O, Gomatam S, Andraca-Carrera E, Hampp C, Yanoff L
N Engl J Med . 2020 Sep; 383(11):1000-1002. PMID: 32905671
No abstract available.
9.
Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97
Hampp C, Swain R, Horgan C, Dee E, Qiang Y, Dutcher S, et al.
Diabetes Care . 2020 Jul; 43(9):2324. PMID: 32647048
No abstract available.
10.
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users
Carnahan R, Gagne J, Hampp C, Leonard C, Toh S, Fuller C, et al.
Pharmaceut Med . 2020 Jan; 33(1):29-43. PMID: 31933271
Background: The US Food and Drug Administration's Sentinel System was established to monitor safety of regulated medical products. Sentinel investigators identified known associations between drugs and adverse events to test...